Guangping Gao, PhD

Guangping Gao is Co-Director of the Li Weibo Institute for Rare Diseases Research, Director of the Horae Gene Therapy Center and Viral Vector Core, Professor of Microbiology and Physiological Systems, and Penelope Booth Rockwell Professor in Biomedical Research at the University of Massachusetts Medical School. Guangping is an elected fellow, both at the US National Academy of Inventors (NAI) and American Academy of Microbiology. Internationally recognized in the field of gene therapy, he has made significant contributions to the development of viral vector gene therapy for rare genetic diseases including to the discovery, development, and engineering of novel viral vectors for in vivo gene delivery, as well as preclinical and clinical gene therapy product development. He has also made significant contributions to the field of viral vector manufacturing for preclinical and clinical gene therapy applications. Guangping has published nearly 300 research papers, six book chapters, and five edited books. He holds 174 patents with 373 more patent applications pending. He serves as Executive Editor-In-Chief of Human Gene Therapy, Senior Editor of the Gene and Cell Therapy book series, Associate Editor of Signal Transduction and Targeted Therapy, and serves on editorial boards of several other gene therapy and virology journals. Guangping was ranked as one of the World Top 20 Translational Researchers in 2017 and 2019 by Nature Biotechnology. He received his PhD in biological sciences from Florida International University and completed his postdoctoral training at the University of Pennsylvania School of Medicine.